10.01.2024 02:05:05
|
P3 Health Partners Reaffirms 2023 Guidance, Sees 2024 Revenue Above View; Stock Up
(RTTNews) - P3 Health Partners Inc. (PIII) reaffirmed guidance for 2023 and announced guidance for 2024.
Looking ahead for fiscal year 2023, the company still expects revenue to be in the range of $1.2 billion to $1.25 billion, and Medicare Advantage Members of 115,000 to 120,000. Analysts polled by Thomson Reuters expect the company to report revenues of $1.22 billion for fiscal year 2023. Analysts' estimates typically exclude special items.
For full-year 2024, the company projects revenue to be between $1.45 billion and $1.55 billion. Analysts expect revenue of $1.41 billion for full-year 2024. Medicare Advantage Members are expected to be in the range of 125,000 to 135,000.
PIII closed Tuesday's regular trading at $1.35 up $0.01 or 0.75%. In the after-hours trading, the stock further gained $0.17 or 12.59%.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu P3 Health Partners Inc Registered Shs -A-mehr Nachrichten
11.11.24 |
Ausblick: P3 Health Partners A öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
06.08.24 |
Ausblick: P3 Health Partners A stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |